Skip to main content

Your search for “Novel Treatment” returned 433 results

UC San Diego Health Ranked #1 by U.S. News & World Report

July 27, 2020

UC San Diego Health is ranked first in San Diego and sixth in California, placing it among the nation’s best hospitals, according to the 2020-2021 U.S. News & World Report. Eight common procedures and conditions were also rated “high performing.”

At Bat Against Rare Blood Cancers

September 20, 2016

University of California researchers to hold meeting in San Diego to discuss hematologic malignancies as part of the University of California Hematologic Malignancies Consortium, a first-of-its-kind research group that brings together the five UC health campuses conducting clinical studies for cancer patients. The consortium currently has four additional clinical trials…

How Gene Therapy May Hold Key to Treating Life-Threatening Cardiac Disease

March 18, 2020

New study finds gene therapy improved cardiac, muscle and liver function in Danon disease mouse models.

UC San Diego Researchers Develop Sensors to Detect and Measure Cancer’s Ability to Spread

December 5, 2018

University of California San Diego School of Medicine researchers engineered sensors to detect and measure the metastatic potential of single cancer cells. Metastasis is attributed as the leading cause of death in people with cancer.

Southern California’s First Real-Time MRI-Guided Gene Therapy for Brain Cancer

August 6, 2013

Neurosurgeons at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center are among the first in the world to utilize real-time magnetic resonance imaging (MRI) guidance for delivery of gene therapy as a potential treatment for brain tumors.

Studies Suggest New Key to “Switching Off” Hypertension

July 22, 2013

A team of University of California, San Diego researchers has designed new compounds that mimic those naturally used by the body to regulate blood pressure. The most promising of them may literally be the key to controlling hypertension, switching off the signaling pathways that lead to the deadly condition.

With OK From FDA, UC San Diego Researchers Prepare to Launch Novel Phage Study

January 8, 2019

FDA approves first U.S. clinical trial of an intravenously administered bacteriophage-based therapy to treat resistant bacterial infections.

UC San Diego a Prominent Presence at Startups Demo Day in D. C.

September 7, 2016

One of the hundreds of companies hatched by the University of California San Diego has a prominent presence in a national showcase of high-potential startups in the nation’s capital. Curtana Pharmaceuticals plays a big role in the high-visibility Washington, D.C. celebration as a major presenter.

Later Hit: Does Cannabis Ease Pain, Speed Recovery in Injured Athletes?

February 1, 2022

The National Football League is funding a novel clinical trial by UC San Diego researchers to assess whether cannabis or CBD provide any post-game pain relief caused by athletic injury. Trial participants will be professional rugby players.

UC San Diego Awarded $8M to Expand Stem Cell Therapy Clinical Trials

November 21, 2022

UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.

Category navigation with Social links